Fiche1957: XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Monday, December 7, 2015

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the…
from Total Knee Replacement Recovery http://totalkneereplacementrecovery.tumblr.com/post/134763901779

from Tumblr http://wendyjborst.tumblr.com/post/134764766300

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)